Identification of Novel IRAK-4 Inhibitors Through Pharmacophore Modeling, Atom-based 3D-QSAR, Docking Strategies and Molecular Dynamics Simulation

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|9|879-887

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.9, 2016-11, pp. : 879-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacophore Modeling, Atom Based 3D-QSAR and Docking Studies of Protein Tyrosine Phosphatase 1B Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 4, 2013-05 ,pp. : 303-319

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Studies Toward the Discovery of Novel Type-II Inhibitors of TrkA: Pharmacophore-based 3D-QSAR Modeling, Database Screening and Molecular Docking

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 526-538

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 8, 2013-10 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite

Toward the Identification of Novel Carbonic Anhydrase XIV Inhibitors using 3D-QSAR Pharmacophore Model, Virtual Screening and Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophoric Modeling and Atom-Based 3D-QSAR of Novel 1-Aryl-3-(1-acylpiperidin-4-yl) Urea as Human Soluble Epoxide Hydrolase Inhibitors (sEHIs)

By  

Medicinal Chemistry, Vol. 7, Iss. 6, 2011-11 ,pp. : 581-592

Bentham Science Publishers

Access to resources Recommend Favorite